Abstract
Appropriate management of Helicobacter pylori infection of the human stomach is evolving and remains a significant clinical challenge. Acute infection results in hypochlorhydria, whereas chronic infection results in either hypo- or hyperchlorhydria, depending upon the anatomic site of infection. Acute hypochlorhydria facilitates survival of the bacterium and its infection of the stomach. Interestingly, most patients chronically infected with H. pylori manifest a pangastritis with reduced acid secretion due to bacterial virulence factors, inflammatory cytokines, and various degrees of gastric atrophy. While these patients are predisposed to develop gastric adenocarcinoma (~1%), there is increasing evidence from population studies that they are also protected from gastroesophageal reflux disease (GERD), Barrett’s esophagus (BE), and esophageal adenocarcinoma (EAC). Eradication of H. pylori, in these patients, may provoke GERD in predisposed individuals and may be a contributory factor for the rising incidence of refractory GERD, BE, and EAC observed in Westernized societies. Only ~10% of chronically infected patients, mainly the young, manifest an antral predominant gastritis with increased acid secretion due to a decrease in somatostatin and increase in gastrin secretion; these patients are predisposed to develop peptic ulcer disease. H. pylori-induced changes in acid secretion, in particular hypochlorhydria, may allow ingested microorganisms to survive transit through the stomach and colonize the distal intestine and colon. Such perturbation of gut microbiota, i.e. dysbiosis, may influence human health and disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alam K, Schubert TT, Bologna SD, Ma CK (1992) Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am J Gastroenterol 87(4):424–428
Amieva M, Peek RM Jr (2016) Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology 150(1):64–78. doi:10.1053/j.gastro.2015.09.004
Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H (2006) Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55(2):158–164
Annibale B, Aprile MR, D’Ambra G, Caruana P, Bordi C, Delle Fave G (2000) Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14(5):625–634
Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A (2011) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 121(8):3088–3093. doi:10.1172/jci45041
Asano S, Kawada K, Kimura T, Grishin AV, Caplan MJ, Takeguchi N (2000) The roles of carbohydrate chains of the beta-subunit on the functional expression of gastric H(+), K(+)-ATPase. J Biol Chem 275(12):8324–8330
Backert S, Blaser MJ (2016) The role of CagA in the gastric biology of Helicobacter pylori. Cancer Res 76(14):4028–4031. doi:10.1158/0008-5472.CAN-16-1680
Backert S, Selbach M (2008) Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10(8):1573–1581
Bakkelund KE, Waldum HL, Nordrum IS, Hauso O, Fossmark R (2010) Long-term gastric changes in achlorhydric H(+)/K(+)-ATPase beta subunit deficient mice. Scand J Gastroenterol 45(9):1042–1047. doi:10.3109/00365521.2010.490952
Bansil R, Celli JP, Hardcastle JM, Turner BS (2013) The influence of mucus microstructure and rheology in Helicobacter pylori infection. Front Immunol 4:310. doi:10.3389/fimmu.2013.00310
Barden S, Lange S, Tegtmeyer N, Conradi J, Sewald N, Backert S, Niemann HH (2013) A helical RGD motif promoting cell adhesion: crystal structures of the Helicobacter pylori type IV secretion system pilus protein CagL. Structure 21(11):1931–1941. doi:10.1016/j.str.2013.08.018
Bayerdorffer E, Oertel H, Lehn N, Kasper G, Mannes GA, Sauerbruch T, Stolte M (1989) Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 42(8):834–839
Bayerdorffer E, Lehn N, Hatz R, Mannes GA, Oertel H, Sauerbruch T, Stolte M (1992) Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 102(5):1575–1582
Beales IL (2001) Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. Dig Dis Sci 46(2):301–306
Beales IL, Calam J (1998) Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42(2):227–234
Beales IL, Calam J (2001) Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C. Gut 48(6):782–789
Beales I, Blaser MJ, Srinivasan S, Calam J, Perez-Perez GI, Yamada T, Scheiman J, Post L, Del Valle J (1997) Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 113(2):465–471
Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE (2010) The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 59(4):441–451. doi:10.1136/gut.2009.178061
Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH (1992) Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 51(Suppl 1):59–67
Bjorkholm B, Zhukhovitsky V, Lofman C, Hulten K, Enroth H, Block M, Rigo R, Falk P, Engstrand L (2000) Helicobacter pylori entry into human gastric epithelial cells: a potential determinant of virulence, persistence, and treatment failures. Helicobacter 5(3):148–154
Black JA, Forte TM, Forte JG (1980) Structure of oxyntic cell membranes during conditions of rest and secretion of HCl as revealed by freeze-fracture. Anat Rec 196(2):163–172
Brand SJ, Stone D (1988) Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest 82(3):1059–1066
Calam J (1998) Helicobacter pylori and somatostatin cells. Eur J Gastroenterol Hepatol 10(4):281–283
Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202–209. doi:10.1038/nature13480
Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC, Kuipers EJ (2010) The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 71(7):1150–1158. doi:10.1016/j.gie.2009.12.029
Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM (2000) Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 95(6):1431–1438
Cave DR, Vargas M (1989) Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 2(8656):187–189
Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, Ewoldt RH, McKinley GH, So P, Erramilli S, Bansil R (2009) Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci 106(34):14321–14326. doi:10.1073/pnas.0903438106
Chen XG, Correa P, Offerhaus J, Rodriguez E, Janney F, Hoffmann E, Fox J, Hunter F, Diavolitsis S (1986) Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol 86(5):575–582
Choi CE, Sonnenberg A, Turner K, Genta RM (2015) High prevalence of gastric preneoplastic lesions in East Asians and Hispanics in the USA. Dig Dis Sci 60(7):2070–2076. doi:10.1007/s10620-015-3591-2
Conradi J, Tegtmeyer N, Woźna M, Wissbrock M, Michalek C, Gagell C, Cover TL, Frank R, Sewald N, Backert S (2012) An RGD helper sequence in CagL of Helicobacter pylori assists in interactions with integrins and injection of CagA. Front Cell Infect Microbiol 2:70. doi:10.3389/fcimb.2012.00070
Correa P (2004) The biological model of gastric carcinogenesis. IARC Sci Publ (157):301–310
Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, Brown C, Haenszel W (1976) Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 57(5):1027–1035
Cover TL (2012) Role of Helicobacter pylori CagL in modulating gastrin expression. Gut. doi:10.1136/gutjnl-2012-302142
Cullen SP, Kearney CJ, Clancy DM, Martin SJ (2015) Diverse activators of the NLRP3 inflammasome promote IL-1beta secretion by triggering necrosis. Cell Rep 11(10):1535–1548. doi:10.1016/j.celrep.2015.05.003
de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ (2008) Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 134(4):945–952. doi:10.1053/j.gastro.2008.01.071
de Vries AC, Haringsma J, de Vries RA, Ter Borg F, van Grieken NC, Meijer GA, van Dekken H, Kuipers EJ (2010) Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 15(4):259–264. doi:10.1111/j.1523-5378.2010.00760.x
Defize J, Goldie J, Hunt RH (1989) Inhibition of acid production by Campylobacter pylori in isolated guinea pig parietal cells. Am J Gastroenterol 96:A114
DelValle J, Sugano K, Yamada T (1987) Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues. Gastroenterology 92(6):1908–1912
DelValle J, Wang L, Gantz I, Yamada T (1992) Characterization of H2 histamine receptor: linkage to both adenylate cyclase and [Ca2+](i) signaling systems. Am J Physiol Gastrointest Liver Physiol 263(6 26–6):G967–G972
Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 20(10):1161–1181
Dubois A, Fiala N, Heman-Ackah LM, Drazek ES, Tarnawski A, Fishbein WN, Perez-Perez GI, Blaser MJ (1994) Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology 106(6):1405–1417
El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE (1997) Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113(1):15–24
El-Zimaity HM, Graham DY (1999) Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney system. Hum Pathol 30(1):72–77
Ernst PB, Peura DA, Crowe SE (2006) The translation of Helicobacter pylori basic research to patient care. Gastroenterology 130(1):188–206
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones N, Render C, Leontiadis GI, Moayyedi P, Marshall JK (2016) The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. doi:10.1053/j.gastro.2016.04.006
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210
Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, El-Serag HB (2012) The association between Barrett’s esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 17(3):163–175. doi:10.1111/j.1523-5378.2011.00931.x
Fletcher J, Wirz A, Young J, Vallance R, McColl KE (2001) Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 121(4):775–783
Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22(3):329–341. doi:10.1016/j.immuni.2005.01.016
Ford AC, Forman D, Hunt R, Yuan Y, Moayyedi P (2015) Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev 7:CD005583. doi:10.1002/14651858.CD005583.pub2
Forte JG, Hanzel DK, Urushidani T, Wolosin JM (1989) Pumps and pathways for gastric HCl secretion. Ann N Y Acad Sci 574:145–158
Fossmark R, Johnsen G, Johanessen E, Waldum HL (2005) Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther 21(2):149–154. doi:10.1111/j.1365-2036.2004.02271.x
Fox JG, Blanco MC, Yan L, Shames B, Polidoro D, Dewhirst FE, Paster BJ (1993) Role of gastric pH in isolation of Helicobacter mustelae from the feces of ferrets. Gastroenterology 104(1):86–92
Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104(34):13780–13785. doi:10.1073/pnas.0706625104
Furuta T, Baba S, Takashima M, Shirai N, Xiao F, Futami H, Arai H, Hanai H, Kaneko E (1999) H+/K+-adenosine triphosphatase mRNA in gastric fundic gland mucosa in patients infected with Helicobacter pylori. Scand J Gastroenterol 34(4):384–390
Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H (2002) Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123(1):92–105
Gillen D, Wirz AA, Ardill JE, McColl KE (1999) Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 116(2):239–247
Gledhill T, Leicester RJ, Addis B, Lightfoot N, Barnard J, Viney N, Darkin D, Hunt RH (1985) Epidemic hypochlorhydria. Br Med J (Clin Res Ed) 290(6479):1383–1386
Gooz M, Hammond CE, Larsen K, Mukhin YV, Smolka AJ (2000) Inhibition of human gastric H(+)-K(+)-ATPase alpha-subunit gene expression by Helicobacter pylori. Am J Physiol Gastrointest Liver Physiol 278(6):G981–G991
Graham DY, Laine L (2016) The Toronto Helicobacter pylori consensus in context. Gastroenterology. doi:10.1053/j.gastro.2016.05.009
Graham DY, Alpert LC, Smith JL, Yoshimura HH (1988) Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 83(9):974–980
Guarner J, Herrera-Goepfert R, Mohar A, Smith C, Schofield A, Halperin D, Sanchez L, Parsonnet J (2003) Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol 34(1):28–31. doi:10.1053/hupa.2003.3
Hammond CE, Beeson C, Suarez G, Peek RM Jr, Backert S, Smolka AJ (2015) Helicobacter pylori virulence factors affecting gastric proton pump expression and acid secretion. Am J Physiol Gastrointest Liver Physiol 309(3):G193–G201. doi:10.1152/ajpgi.00099.2015
Harford WV, Barnett C, Lee E, Perez-Perez G, Blaser MJ, Peterson WL (2000) Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut 47(4):467–472
Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Pena A, Rollan A, Viviani P, Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE, Smith PD (2008) Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134(2):491–499. doi:10.1053/j.gastro.2007.11.006
He C, Yang Z, Lu N (2016) Imbalance of gastrointestinal microbiota in the pathogenesis of Helicobacter pylori-associated diseases. Helicobacter. doi:10.1111/hel.12297
Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49(3):347–353
Hidaka E, Ota H, Hidaka H, Hayama M, Matsuzawa K, Akamatsu T, Nakayama J, Katsuyama T (2001) Helicobacter pylori and two ultrastructurally distinct layers of gastric mucous cell mucins in the surface mucous gel layer. Gut 49(4):474–480
Hoffman JS, King WW, Fox JG, Janik D, Cave DR (1995) Rabbit and ferret parietal cell inhibition by Helicobacter species. Dig Dis Sci 40(1):147–152
Holcombe C (1992) Helicobacter pylori: the African enigma. Gut 33(4):429–431
Holm L, Agren J, Persson AE (1992) Stimulation of acid secretion increases the gastric gland luminal pressure in the rat. Gastroenterology 103:1797–1803
Holtmann G, Cain C, Malfertheiner P (1999) Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 117(1):11–16
Huang JY, Sweeney EG, Sigal M, Zhang HC, Remington SJ, Cantrell MA, Kuo CJ, Guillemin K, Amieva MR (2015) Chemodetection and destruction of host urea allows Helicobacter pylori to locate the epithelium. Cell Host Microbe 18(2):147–156. doi:10.1016/j.chom.2015.07.002
Hunt RH, Scarpignato C (2015) Potassium-competitive acid blockers (P-CABs): are they finally ready for prime time in acid-related disease [quest]. Clin Trans Gastroenterol 6:e119. doi:10.1038/ctg.2015.39
Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M, Sonnenberg A, Sugano K, Tack J (2015) The stomach in health and disease. Gut 64(10):1650–1668. doi:10.1136/gutjnl-2014-307595
Inoue H, Imoto I, Taguchi Y, Kuroda M, Nakamura M, Horiki N, Oka S, Gabazza EC, Adachi Y (2004) Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia. Scand J Gastroenterol 39(11):1061–1065. doi:10.1080/00365520410008006
Jablonowski H, Hengels KJ, Kraemer N, Geis G, Opferkuch W, Strohmeyer G (1994a) Effect of Helicobacter pylori on dibutyryl c-AMP-stimulated acid secretion by human parietal cells. Hepatogastroenterology 41(6):546–548
Jablonowski H, Hengels KJ, Kraemer N, Geis G, Opferkuch W, Strohmeyer G (1994b) Effects of Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells. Gut 35(6):755–757
Kabisch R, Mejias-Luque R, Gerhard M, Prinz C (2014) Involvement of toll-like receptors on Helicobacter pylori-induced immunity. PLoS ONE 9(8):e104804. doi:10.1371/journal.pone.0104804
Kandulski A, Wex T, Kuester D, Peitz U, Gebert I, Roessner A, Malfertheiner P (2008) Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter 13(4):295–303. doi:10.1111/j.1523-5378.2008.00612.x
Kawanaka M, Watari J, Kamiya N, Yamasaki T, Kondo T, Toyoshima F, Ikehara H, Tomita T, Oshima T, Fukui H, Daimon T, Das KM, Miwa H (2016) Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial. Br J Cancer 114(1):21–29. doi:10.1038/bjc.2015.418
Khulusi S, Mendall MA, Patel P, Levy J, Badve S, Northfield TC (1995) Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 37(3):319–324
Kim GH, Liang PS, Bang SJ, Hwang JH (2016) Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc 84(1):18–28. doi:10.1016/j.gie.2016.02.028
Kobayashi H, Kamiya S, Suzuki T, Kohda K, Muramatsu S, Kurumada T, Ohta U, Miyazawa M, Kimura N, Mutoh N, Shirai T, Takagi A, Harasawa S, Tani N, Miwa T (1996) The effect of Helicobacter pylori on gastric acid secretion by isolated parietal cells from a guinea pig. Association with production of vacuolating toxin by H. pylori. Scand J Gastroenterol 31(5):428–433
Koch KN, Hartung ML, Urban S, Kyburz A, Bahlmann AS, Lind J, Backert S, Taube C, Müller A (2015) Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J Clin Invest 125(8):3297–3302. doi:10.1172/JCI79337
Kodaman N, Pazos A, Schneider BG, Piazuelo MB, Mera R, Sobota RS, Sicinschi LA, Shaffer CL, Romero-Gallo J, de Sablet T, Harder RH, Bravo LE, Peek RM Jr, Wilson KT, Cover TL, Williams SM, Correa P (2014) Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A 111(4):1455–1460. doi:10.1073/pnas.1318093111
Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W, Backert S (2007) Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449(7164):862–866
Labenz J, Malfertheiner P (1997) Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 41(3):277–280
Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G (1997a) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112(5):1442–1447
Labenz J, Tillenburg B, Peitz U, Borsch G, Idstrom JP, Verdu E, Stolte M, Blum AL (1997b) Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol 92(4):576–581
Labenz J, Tillenburg B, Peitz U, Verdu E, Stolte M, Borsch G, Blum AL (1997c) Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 41(1):33–36
Lee A, Krakowka S, Fox JG, Otto G, Eaton KA, Murphy JC (1992) Role of Helicobacter felis in chronic canine gastritis. Vet Pathol 29(6):487–494
Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY (2016) Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 150(5):1113–1124 e1115. doi:10.1053/j.gastro.2016.01.028
Levi S, Beardshall K, Swift I, Foulkes W, Playford R, Ghosh P, Calam J (1989) Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ 299(6714):1504–1505
Li W, Shi YH, Yang RL, Cui J, Xiao Y, Le GW (2010) Reactive oxygen species serve as signals mediating glucose-stimulated somatostatin secretion from cultured rat gastric primary D-cells. Free Radical Res 44(6):614–623. doi:10.3109/10715761003713549
Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U (2016) Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study. Am J Gastroenterol. doi:10.1038/ajg.2016.188
Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y (2009) Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 1173:640–648. doi:10.1111/j.1749-6632.2009.04673.x
Lim JH, Kim N, Lee HS, Choe G, Jo SY, Chon I, Choi C, Yoon H, Shin CM, Park YS, Lee DH, Jung HC (2013) Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia. Gut Liver 7(1):41–50. doi:10.5009/gnl.2013.7.1.41
Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, Potter A, Varro A, Eibach D, Suerbaum S, Wang TC, Fox JG (2011) Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology 140(1):210–220. doi:10.1053/j.gastro.2010.09.048
Louw JA, Falck V, van Rensburg C, Zak J, Adams G, Marks IN (1993) Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers. J Clin Pathol 46(8):754–756
Luther J, Dave M, Higgins PD, Kao JY (2010) Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 16(6): 1077–1084
Manela FD, Ren J, Gao J, McGuigan JE, Harty RF (1995) Calcitonin gene-related peptide modulates acid-mediated regulation of somatostatin and gastrin release from rat antrum. Gastroenterology 109(3):701–706
Marshall BJ (1995) Helicobacter pylori in peptic ulcer: have Koch’s postulates been fulfilled? Ann Med 27(5):565–568
Matsui H, Nagano Y, Shimokawa O, Kaneko T, Rai K, Udo J, Hirayama A, Nakamura Y, Indo HP, Majima HJ, Hyodo I (2011) Gastric acid induces mitochondrial superoxide production and lipid peroxidation in gastric epithelial cells. J Gastroenterol 46(10):1167–1176. doi:10.1007/s00535-011-0434-6
Merchant JL (2005) Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology 129(3):1079–1082
Meyer-Rosberg K, Scott DR, Rex D, Melchers K, Sachs G (1996) The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 111(4):886–900
Mills JC, Syder AJ, Hong CV, Guruge JL, Raaii F, Gordon JI (2001) A molecular profile of the mouse gastric parietal cell with and without exposure to Helicobacter pylori. Proc Natl Acad Sci U S A 98(24):13687–13692
Mitchell DR, Derakhshan MH, Robertson EV, McColl KE (2016) The role of the acid pocket in gastroesophageal reflux disease. J Clin Gastroenterol 50(2):111–119. doi:10.1097/mcg.0000000000000439
Morris A, Nicholson G (1987) Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 82(3):192–199
Moss SF, Legon S, Bishop AE, Polak JM, Calam J (1992) Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340(8825):930–932
Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S (2012) c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. doi:10.1172/jci61143
Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF (1994) Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 35(5):615–618
Olbe L, Hamlet A, Dalenback J, Fandriks L (1996) A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 110(5):1386–1394
Otake K, Sakurai Y, Nishida H, Fukui H, Tagawa Y, Yamasaki H, Karashima M, Otsuka K, Inatomi N (2016) Characteristics of the Novel potassium-competitive acid blocker vonoprazan fumarate (TAK-438). Adv Ther. doi:10.1007/s12325-016-0345-2
Padol IT, Hunt RH (2004) Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands. Gut 53(8):1075–1081. doi:10.1136/gut.2003.026435
Pandolfino JE, Zhang Q, Ghosh SK, Post J, Kwiatek M, Kahrilas PJ (2007) Acidity surrounding the squamocolumnar junction in GERD patients: “acid pocket” versus “acid film”. Am J Gastroenterol 102(12):2633–2641. doi:10.1111/j.1572-0241.2007.01488.x
Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324–335. doi:10.1016/j.chom.2011.10.003
Polk DB, Peek RM (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10(6):403–414
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Jian M, Zhou Y, Li Y, Zhang X, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65. doi:10.1038/nature08821
Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C (2006) CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131(2):525–537. doi:10.1053/j.gastro.2006.05.001
Raghunath A, Hungin AP, Wooff D, Childs S (2003) Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326(7392):737. doi:10.1136/bmj.326.7392.737
Ramsey EJ, Carey KV, Peterson WL, Jackson JJ, Murphy FK, Read NW, Taylor KB, Trier JS, Fordtran JS (1979) Epidemic gastritis with hypochlorhydria. Gastroenterology 76(6):1449–1457
Reimer C, Sondergaard B, Hilsted L, Bytzer P (2009) Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 137(1):80–87, 87 e81
Riley DR, Sieber KB, Robinson KM, White JR, Ganesan A, Nourbakhsh S, Dunning Hotopp JC (2013) Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol 9(6):e1003107. doi:10.1371/journal.pcbi.1003107
Roepke TK, Anantharam A, Kirchhoff P, Busque SM, Young JB, Geibel JP, Lerner DJ, Abbott GW (2006) The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion. J Biol Chem 281(33):23740–23747. doi:10.1074/jbc.M604155200
Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G (2007) Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 5(12):1413–1417.e1412. Epub 2007 Nov 1417
Rugge M (2015) Gastric cancer risk in patients with Helicobacter pylori infection and following its eradication. Gastroenterol Clin North Am 44(3):609–624. doi:10.1016/j.gtc.2015.05.009
Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P (2016) Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut 65(5):721–725. doi:10.1136/gutjnl-2015-310846
Sachs G (1987) The gastric proton pump: The H+, K+-ATPase. In: Johnson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, pp 865–881
Saha A, Hammond CE, Trojanowska M, Smolka AJ (2008) Helicobacter pylori-induced H, K-ATPase {alpha}-subunit gene repression is mediated by NF-{kappa}B p50 homodimer promoter binding. Am J Physiol Gastrointest Liver Physiol 294(3):G795–G807. doi:10.1152/ajpgi.00431.2007
Saha A, Backert S, Hammond CE, Gooz M, Smolka AJ (2010a) Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology 139(1):239–248
Saha A, Hammond CE, Beeson C, Peek RM, Smolka AJ (2010b) Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa. Gut 59(7):874–881. doi:10.1136/gut.2009.194795
Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y (1991) A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol 86(3):285–291
Satoh K, Kimura K, Taniguchi Y, Kihira K, Takimoto T, Saifuku K, Kawata H, Tokumaru K, Kojima T, Seki M, Ido K, Fujioka T (1998) Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 93(4):569–573. doi:10.1111/j.1572-0241.1998.166_b.x
Schepp W, Dehne K, Herrmuth H, Pfeffer K, Prinz C (1998) Identification and functional importance of IL-1 receptors on rat parietal cells. Am J Physiol 275(5 Pt 1):G1094–G1105
Schubert ML, Kaunitz JD (2015) Gastric secretion. In: Feldman M, Friedman DB, Brandt LJ (eds) Sleisenger and Fordtran’s gastrointestinal and liver disease. Saunders Elsevier, Philadelphia, pp 839–855
Schubert ML, Edwards NF, Makhlouf GM (1988) Regulation of gastric somatostatin secretion in the mouse by luminal acidity: a local feedback mechanism. Gastroenterology 94(2):317–322
Sheh A, Fox JG (2013) The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes 4(6):505–531
Shiota S, Singh S, Anshasi A, El-Serag HB (2015) Prevalence of Barrett’s esophagus in Asian Countries: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 13(11):1907–1918. doi:10.1016/j.cgh.2015.07.050
Sigal M, Rothenberg ME, Logan CY, Lee JY, Honaker RW, Cooper RL, Passarelli B, Camorlinga M, Bouley DM, Alvarez G, Nusse R, Torres J, Amieva MR (2015) Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands. Gastroenterology 148(7):1392–1404 e1321. doi:10.1053/j.gastro.2015.02.049
Smolka AJ, Backert S (2012) How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol 47(6):609–618. doi:10.1007/s00535-012-0592-1
Smolka A, Helander HF, Sachs G (1983) Monoclonal antibodies against gastric H++K+ ATPase. Am J Physiol 245:589–596
Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, Heatley RV, Axon AT (1991) Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 32(11):1415–1418
Sommer F, Backhed F (2013) The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11(4):227–238. doi:10.1038/nrmicro2974
Song MJ, Park DI, Hwang SJ, Kim ER, Kim YH, Jang BI, Lee SH, Ji JS, Shin SJ (2009a) The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study. Korean J Gastroenterol 53(6):341–347
Song P, Groos S, Riederer B, Feng Z, Krabbenhoft A, Smolka A, Seidler U (2009b) KCNQ1 is the luminal K+ recycling channel during stimulation of gastric acid secretion. J Physiol 587(Pt 15):3955–3965. doi:10.1113/jphysiol.2009.173302
Song P, Groos S, Riederer B, Feng Z, Krabbenhoft A, Manns MP, Smolka A, Hagen SJ, Neusch C, Seidler U (2011) Kir4.1 channel expression is essential for parietal cell control of acid secretion. J Biol Chem 286(16):14120–14128. doi:10.1074/jbc.M110.151191
Soroka CJ, Chew CS, Hanzel DK, Smolka A, Modlin IM, Goldenring JR (1993) Characterization of membrane and cytoskeletal compartments in cultured parietal cells: immunofluorescence and confocal microscopic examination. Eur J Cell Biol 60(1):76–87
Spicer Z, Miller ML, Andringa A, Riddle TM, Duffy JJ, Doetschman T, Shull GE (2000) Stomachs of mice lacking the gastric H, K-ATPase alpha -subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J Biol Chem 275(28):21555–21565. doi:10.1074/jbc.M001558200
Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P (2015) Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64(9):1353–1367. doi:10.1136/gutjnl-2015-309252
Tagkalidis PP, Royce SG, Macrae FA, Bhathal PS (2002) Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use. Eur J Gastroenterol Hepatol 14(4):453–456
Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E (2001) Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 48(6):765–773
Tanaka S, Meiselman HH, Engel E, Guth PH, Furukawa O, Wenby RB, Lee J, Kaunitz JD (2002) Regional differences of H+, HCO3−, and CO2 diffusion through native porcine gastroduodenal mucus. Dig Dis Sci 47(5):967–973
Tricottet V, Bruneval P, Vire O, Camilleri JP, Bloch F, Bonte N, Roge J (1986) Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 10(2):113–122
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11):784–789
Vela MF (2014) Medical treatments of GERD: the old and new. Gastroenterol Clin North Am 43(1):121–133. doi:10.1016/j.gtc.2013.12.001
Verdu EF, Armstrong D, Idstrom JP, Labenz J, Stolte M, Dorta G, Borsch G, Blum AL (1995) Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 37(6):743–748
Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5(11):1166–1174
von Arnim U, Wex T, Link A, Messerschmidt M, Venerito M, Miehlke S, Malfertheiner P (2016) Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis. Aliment Pharmacol Ther 43(7):825–830. doi:10.1111/apt.13560
Wallace JL, Cucala M, Mugridge K, Parente L (1991) Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 261(4 Pt 1):G559–G564
Wiedemann T, Hofbaur S, Tegtmeyer N, Huber S, Sewald N, Wessler S, Backert S, Rieder G (2012) Helicobacter pylori CagL dependent induction of gastrin expression via a novel alphavbeta5-integrin-integrin linked kinase signalling complex. Gut. doi:10.1136/gutjnl-2011-300525
Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291(2):187–194
Wu GD, Lewis JD (2013) Analysis of the human gut microbiome and association with disease. Clin Gastroenterol Hepatol 11(7):774–777. doi:10.1016/j.cgh.2013.03.038
Wu JC, Sung JJ, Chan FK, Ching JY, Ng AC, Go MY, Wong SK, Ng EK, Chung SC (2000) Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 14(4):427–432
Yakabi K, Mimura H, Iwabuchi H, Ro S, Kamiichi H, Miura S, Nakamura T (2003) Neutrophil-derived hydroxyl radicals mediate interleukin-8-induced increases in tetragastrin-stimulated acid secretion in rats. Dig Dis Sci 48(6):1081–1087
Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ (2016) Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut 65(4):563–574. doi:10.1136/gutjnl-2014-308588
Zaki M, Coudron PE, McCuen RW, Harrington L, Chu S, Schubert ML (2013) H. pylori acutely inhibits gastric secretion by activating CGRP sensory neurons coupled to stimulation of somatostatin and inhibition of histamine secretion. Am J Physiol Gastrointest Liver Physiol 304(8):G715–G722. doi:10.1152/ajpgi.00187.2012
Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL (2002) Hypergastrinemia in response to gastric inflammation suppresses somatostatin. Am J Physiol Gastrointest Liver Physiol 282(1):G175–G183. doi:10.1152/ajpgi.00287.2001
Zavros Y, Eaton KA, Kang W, Rathinavelu S, Katukuri V, Kao JY, Samuelson LC, Merchant JL (2005) Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 24(14):2354–2366
Zhang YM, Hammond CE, Barth JL, Argraves WS, Backert S, Peek RM, Smolka AJ (2014) Helicobacter pylori-induced post-transcriptional regulation of H, K-ATPase alpha subunit gene by miRNA. Am J Physiol Gastrointest Liver Physiol 306:G606–G613
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Smolka, A.J., Schubert, M.L. (2017). Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease. In: Tegtmeyer, N., Backert, S. (eds) Molecular Pathogenesis and Signal Transduction by Helicobacter pylori. Current Topics in Microbiology and Immunology, vol 400. Springer, Cham. https://doi.org/10.1007/978-3-319-50520-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-50520-6_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50519-0
Online ISBN: 978-3-319-50520-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)